User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 5 results.
    • Journal article
    Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
    Morschhauser, Franck Fowler, Nathan H Feugier, Pierre Bouabdallah, Reda Tilly, Hervé Palomba, M Lia Fruchart, Christophe Libby, Edward N Casasnovas, Rene-Olivier Flinn, Ian W Haioun, Corinne Maisonneuve, Hervé Ysebaert, Loic Bartlett, Nancy L Bouabdallah, Kamal Brice, Pauline Ribrag, Vincent Daguindau, Nicolas Le Gouill, Steven Pica, Gian M Martin Garcia-Sancho, Alejandro López-Guillermo, Armando Larouche, Jean-François Ando, Kiyoshi Gomes da Silva, Maria André, Marc[UCL] Zachée, Pierre Sehn, Laurie H Tobinai, Kensei Cartron, Guillaume Liu, David Wang, Jianming Xerri, Luc Salles, Gilles A RELEVANCE Trial Investigators (2018) The New England journal of medicine — Vol. 379, no. 10, p. 934-947 (2018)
    • Journal article
    Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
    Burger, Jan A Tedeschi, Alessandra Barr, Paul M Robak, Tadeusz Owen, Carolyn Ghia, Paolo Bairey, Osnat Hillmen, Peter Bartlett, Nancy L Li, Jianyong Simpson, David Grosicki, Sebastian Devereux, Stephen McCarthy, Helen Coutre, Steven Quach, Hang Gaidano, Gianluca Maslyak, Zvenyslava Stevens, Don A Janssens, Ann Van Den Neste, Eric[UCL] (2015) New England Journal of Medicine — Vol. 373, no. 25, p. 2425-2437 (2015)
    • Journal article
    Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma.
    Neelapu, Sattva S Locke, Frederick L Bartlett, Nancy L Lekakis, Lazaros J Reagan, Patrick M Miklos, David B Jacobson, Caron A Braunschweig, Ira Oluwole, Olalekan O Siddiqi, Tanya Lin, Yi Crump, Michael Kuruvilla, John Van Den Neste, Eric[UCL] Farooq, Umar Navale, Lynn DePuy, Venita Kim, Jenny J Gisselbrecht, Christian (2021) Blood advances — Vol. 5, no. 20, p. 4149-4155 (2021)
    • Journal article
    Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
    Chanan-Khan, Asher Cramer, Paula Demirkan, Fatih Fraser, Graeme Silva, Rodrigo Santucci Grosicki, Sebastian Pristupa, Aleksander Janssens, Ann Mayer, Jiri Bartlett, Nancy L Dilhuydy, Marie-Sarah Pylypenko, Halyna Loscertales, Javier Avigdor, Abraham Rule, Simon Villa, Diego Samoilova, Olga Panagiotidis, Panagiots Goy, Andre Mato, Anthony HELIOS investigators Van Den Neste, Eric[UCL] (2016) The Lancet Oncology — Vol. 17, no. 2, p. 200-211 (2016)
    • Journal article
    Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.
    Morschhauser, Franck Nastoupil, Loretta Feugier, Pierre Schiano de Colella, Jean-Marc Tilly, Hervé Palomba, Maria Lia Bachy, Emmanuel Fruchart, Christophe Libby, Edward N Casasnovas, Rene-Olivier Flinn, Ian W Haioun, Corinne Maisonneuve, Hervé Ysebaert, Loic Bartlett, Nancy L Bouabdallah, Kamal Brice, Pauline Ribrag, Vincent Le Gouill, Steven Daguindau, Nicolas Guidez, Stéphanie Pica, Gian Matteo García-Sancho, Alejandro Martín López-Guillermo, Armondo Larouche, Jean-François Ando, Kiyoshi Gomes da Silva, Maria André, Marc[UCL] Kalung, Wu Sehn, Laurie H Izutsu, Koji Cartron, Guillaume Gkasiamis, Argyrios Crowe, Russell Xerri, Luc Fowler, Nathan H Salles, Gilles (2022) Journal of clinical oncology — Vol. 40, no. 28, p. 239-3245 (2022)